SlideShare ist ein Scribd-Unternehmen logo
1 von 4
Downloaden Sie, um offline zu lesen
GRASIM INDUSTRIES LIMITED
Current Price:
Price (`) 3768.20
52 W H/L( ) 4023.60/3222.60
Mkt. Cap.( Cr) 34612.35
Latest Equity(Subscribed) 91.85
Latest Reserve (cons.) 22988.71
Latest EPS (cons.) -Unit Curr. 190.30
Latest P/E Ratio -cons 19.80
LatestBookvalue(cons.)-UnitCurr. 2512.75
Latest P/BV - cons 1.50
Dividend Yield -% 0.48
Face Value 10.00
`
`
VALUE PARAMETERS
Consolidated Results
In Cr.
`3768.20`3768.20
STOCK DATA
BSE Code 500300
NSE Symbol GRASIM
Reuters GRAS.BO
Bloomberg GRASIM IN
SHARE HOLDING PATTERN (%)
Description as on % of Holding
30/06/2015
Foreign 40.35
Institutions 17.57
Govt Holding 0.00
Non Promoter Corp. Hold. 6.76
Promoters 25.51
Public & Others 9.81
Grasim Industries, a flagship company of the Aditya Birla Group,has reported improved
performance for the quarter ended June 2015, amidst challenging market conditions. Its
consolidated net profit declined by 1% to `484.67 crore despite 7% jump in revenue to
8599.07 crore. OPM improved by 130 bps to 16.5%, due to drop in raw material and power &
fuel cost partially offset by rise in freight and employee cost, thus, operating profit inclined by
16% to 1417.06 crore. With gain in interest outgo by 35% to 171.30 crore and depreciation
by 13% to 403.04 crore, the PBT dropped by 5% to 956.64 crore.
Consolidated results for the June quarter
Topline jumps 7%-Consolidated net sales revenue of the company jumped 7% to 8599.07
crore for the first quarter ended June 2015, aided by growth in turnover for all three businesses,
notably the VSF segment.
The revenue from cement (Grey, White and Allied Products) division (contributes 74% of total
revenue) grew 7% to 6432.15 crore, Viscose Staple Fibre and Wood Pulp division (contributes
19% of total revenue) rose 7% to 1664.37 crore and Chemicals (Caustic Soda and Allied
Chemicals) segment (contributes 6% of total revenue) climbed 17% to 485.18 crore. Revenue
from other segments (constitutes mainly textiles and contributes 2% of total revenue) fell 8%
to 136.65 crore.
OPM improves to 16.5% - Operating margin (OPM) inclined 130 bps to 16.5%. The
improvement in OPM seems largely on account of decrease in power & fuel costs by 240 bps to
17.6%, raw material cost by 100 bps to 23.3%, and other cost by 40 bps to 14.7% as
percentage to sales and net of stock adjustments. However, freight & handling costs increased
by 210 bps to 19.7% and employee benefits cost jumped 30 bps to 6.5% during the period. As a
result, operating profit advanced by 16% at 1417.06 crore.
`
` `
` `
`
`
`
`
`
`
1
Particulars Qtr Ending Qtr Ending Var.
June 15 14 (%)
Total Income 8599.07 8045.04 7
OPM (%) 16.48 15.14 9
OP 1417.06 1218.22 16
Other income 113.92 269.61 -58
PBIDT 1530.98 1487.83 3
Net Finance Charges 171.30 126.49 35
PBDT 1359.68 1361.34 0
Depreciation 403.04 357.76 13
PBT 956.64 1003.58 -5
Tax expense 281.07 304.05 -8
PAT 675.57 699.53 -3
Minority Interest 234.77 250.30 -6
Share of Profit of Associates 43.87 37.90 16
Profit after Minority Interest and
Share of profit of Associates
EPS (`) 52.76 53.04
June
484.67 487.13 -1
August 11, 2015
2
At segment level, PBIT of cement business gained 14% to 921.52 crore and Chemicals
business rose 4% to 69.60 crore, while VSFand Wood Pulp business PBIT zoomed to 68.77
crore from 19.81 crore in previous corresponding quarter.The margins of cement business
escalated 90 bps to 14.3%, while the VSF and Wood Pulp businessmargins grew 290 bps to
4.1% while margin of chemicals business sank 180 bps to 14.3%.
Bottomline falls 1% on higher interest, depreciation- The other income was down 58%
to 113.92 crore, thus the PBIDT rose by 3% to 1530.98 crore. The Company interest cost
jumped 35% to 171.30and depreciation rose13% to 403.04 crore.Thus, the PBT shrank by
5% to 956.64 crore. The effective tax rate was down 90 bps to 29.4% during the quarter, thus,
Tax Expense declined 8% to Rs 281.07 crore. After deducting tax expenses, the PAT before MI
and Share of profits from Associate declined by 3% to 675.57 crore. After accounting Minority
interest of Rs 234.77 crore, down 6%, and Share of profits from associates of 43.87 crore, up
16%, respectively, Consolidated Net Profit was down 1% to 484.67 crore.
`
` `
`
` `
` `
`
`
`
`
Consolidated Results
In Cr.
Particulars Qtr Ending Qtr Ending % Var.
June 15 June 14 total (%)
Segment Revenue
Viscose Staple Fibre and Wood Pulp 1664.37 1558.58 19 7
Cement - Grey, White and Allied Products 6432.15 6032.36 74 7
Chemicals-CausticSodaandAlliedChemicals 485.18 414.20 6 17
Others 136.65 148.57 2 -8
Total 8718.35 8153.71 100 7
Less: Inter-segment Revenue 119.28 108.67 13
Net Sales/Income from Operations 8599.07 8045.04 10
Segment Results
(Profit before Finance Cost & Taxes)
Viscose Staple Fibre and Wood Pulp 68.77 19.81 6 247
Cement - Grey, White and Allied Products 921.52 809.38 86 14
Chemicals - Caustic Soda and Allied Chemicals 69.60 66.83 6 4
Others 11.56 10.70 1 8
Total 1071.45 906.72 100 18
Less: Finance Costs 171.30 126.49 35
Net Unallocable Income/ (Expenditure) 56.49 223.35 -75
Total Profit before EO and tax 956.64 1003.58 -5
Add: EO 0.00 0.00
Profit before Tax 956.64 1003.58 -5
Capital Employed
(Segment Assets-Segment Liabilities)
Viscose Staple Fibre and Wood Pulp 6979.85 7167.01 15 -3
Cement - Grey, White and Allied Products 30472.83 28197.99 65 8
Chemicals - Caustic Soda and Allied Chemicals 1949.04 1869.58 4 4
Others 318.08 287.57 1 11
Unallocated 6803.86 6684.11 15 2
Total 46523.66 44206.26 100 5
of
3
Viscose Staple Fibre (VSF)
Revenue increased by 15% driven by higher sales volume at 103K MT, up 19%. EBIDTA surged
by 72% at 139 crore. with expanded volumes and a decline in pulp and other input cost. The
production at the newly commissioned Vilayat plant has ramped up. It achieved a capacity
utilisation of ~82%. The volume growth would have been higher, had there been no plant
stoppage at Nagda for two months due to the water shortage. Operations at Nagda resumed
from the last week of June 2015.
Chemical Business
In the Chemical business, revenue soared by 17% as Epoxy volume almost doubled with
ramping up of plant utilisation. Caustic soda sales volume was maintained at 98K Tons. EBITDA
increased by 3% at 94 crore.
The merger scheme of Aditya Birla Chemicals India Ltd. (ABCIL) with the Company has been
approved by the Shareholders and Creditors of both the Companies. Post-merger, the caustic
soda capacity of the Company will increase from 452K TPA to 804K TPA. The scheme will be
effective from 1st April, 2015 upon receipt of requisite regulatory approvals inter-alia from
Competition Commission of India and High courts, expected by Q3 FY16. Therefore, the
Company's results do not include EBITDA of 78 crore. and PAT of 20 crore. reported by ABCIL
for the current quarter.
Cement Subsidiary (UltraTech Cement)
Amidst subdued demand in the Cement sector due to slowdown in construction activities,
UltraTech Cement has reported better performance. Its revenue for the quarter stood at 6,432
crore, up by 7% as compared to 6,032 crore in the corresponding quarter last year. The
combined cement and clinker sales volume was 13.0 million tonnes against 12.4 million tonnes
last year. EBITDA was 1,282 crore ( 1,296 crore) and Net profit was 591 crore ( 627 crore).
With the reduction in fuel pricesand higher pet coke consumption, energy costs declined by 7%.
Its benefit was partially offset by the increase in railway freight. Input prices remained stable,
except for the rise in royalty on limestone and levies under the Mines and Mineral (Development
and Regulation) Amendment Act, 2015.
Outlook
In the VSF business, prices are likely to be influenced by the development in the industry
inChina amidst increase in the input prices and resumption of operations at some of the shut
capacities. The Company's new plant at Vilayat with a higher share of speciality product will
improve its product mix and realisations. The recently launched brand 'Liva' has met with good
response from value chain and consumers. The Company is closely working with the brands,
designers and retailers to expand its domestic market.
In the Chemical business, the scale of operations will rise significantly post the merger of
ABCILwith the Company.
In Cement, the demand is expected to be higher with the Government's focus on
infrastructuredevelopment, housing sector, smart cities etc. and the softening of interest rates.
The Companyis well positioned across the country to cater growth in demand.The Company
enjoys a leadership position in all its businesses: Cement, Viscose Staple Fibre andChemicals,
which has been further strengthened having made an investment of US$4 billion overlast five
years. The Company is well poised to reap the benefits of these investments withramping up of
capacity utilisation and expected upturn in the business cycle led byaccelerated growth in the
economy.
`
`
` `
`
`
` ` ` `
3
SMC Global Securities Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a further public offering of its equity shares and has filed the Draft Red Herring
Prospectus with the Securities and Exchange Board of India (“SEBI”) and the Stock Exchanges. The Draft Red Herring Prospectus is available on the website of SEBI at www.sebi.gov.in and on the websites of the
Book Running Lead Manager i.e., ICICI Securities Limited at www.icicisecurities.com and the Co- Book Running Lead Manager i.e., Elara Capital (India) Private Limited at www.elaracapital.com . Investors should
note that investment in equity shares involves a high degree of risk and for details relating to the same, please see the section titled “Risk Factors” of the aforementioned offer document.
Disclaimer: This report is for the personal information of the authorized recipient and doesn't construe to be any investment, legal or taxation advice to you. It is only for private circulation and use .The report is based
upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. No action is solicited on the basis of the contents of the report. The report
should not be reproduced or redistributed to any other person(s)in any form without prior written permission of the SMC. The contents of this material are general and are neither comprehensive nor inclusive. Neither
SMC nor any of its affiliates, associates, representatives, directors or employees shall be responsible for any loss or damage that may arise to any person due to any action taken on the basis of this report. It does not
constitute personal recommendations or take into account the particular investment objectives, financial situations or needs of an individual client or a corporate/s or any entity/s.All investments involve risk and past
performance doesn't guarantee future results. The value of, and income from investments may vary because of the changes in the macro and micro factors given at a certain period of time. The person should use
his/her own judgment while taking investment decisions. Please note that we and our affiliates, officers, directors, and employees, including persons involved in the preparation or issuance if this material;(a) from
time to time, may have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned here in or (b) be engaged in any other transaction involving such securities and earn brokerage or
other compensation or act as a market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform investment banking services for such company(ies) or act as advisor
or lender/borrower to such company(ies) or (c) may have any other potential conflict of interest with respect to any recommendation and related information and opinions.All disputes shall be subject to the exclusive
jurisdiction of Delhi High court.
Corporate Office:
11/6B, Shanti Chamber,
Pusa Road, New Delhi - 110005
Tel: +91-11-30111000
www.smcindiaonline.com
Mumbai Office:
Dheeraj Sagar, 1st Floor,
Opp. Goregaon sports club, link road
Malad (West), Mumbai - 400064
Tel: 91-22-67341600, Fax: 91-22-28805606
Kolkata Office:
18, Rabindra Sarani,
"Poddar Court", Gate No. 4,
4th Floor, Kolkata - 700001
Tel: 91-33-39847000, Fax: 91-33-39847004
E-mail: researchfeedback@smcindiaonline.com
Âź
SMC Research also available on Reuters
SMC Global Securities Ltd. (hereinafter referred to as “SMC”) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and its associate is member of MCX stock
Exchange Limited. It is also registered as a Depository Participant with CDSL and NSDL. Its associates merchant banker and Portfolio Manager are registered with SEBI and NBFC registered with RBI. It also has
registration withAMFI as a Mutual Fund Distributor.
SMC has applied with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. SMC or its associates has not been debarred/ suspended by SEBI or any other regulatory
authority for accessing /dealing in securities Market.
SMC or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered byAnalyst. SMC or its associates and relatives does not have any
material conflict of interest. SMC or its associates/analyst has not received any compensation from the company covered byAnalyst during the past twelve months. The subject company has not been a client of SMC
during the past twelve months. SMC or its associates has not received any compensation or other benefits from the company covered by analyst or third party in connection with the research report. TheAnalyst has
not served as an officer, director or employee of company covered byAnalyst and SMC has not been engaged in market making activity of the company covered byAnalyst.
The views expressed are based solely on information available publicly available/internal data/ other reliable sources believed to be true.
SMC does not represent/ provide any warranty express or implied to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before
making any investment decision.
SMC Research Desk
Source: Company Website Reuters Capitaline

Weitere Àhnliche Inhalte

Was ist angesagt?

GSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; Buy
GSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; BuyGSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; Buy
GSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; BuyIndiaNotes.com
 
Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]IndiaNotes.com
 
Firstcall simmonds marshall_ltd_1_july15
Firstcall simmonds marshall_ltd_1_july15Firstcall simmonds marshall_ltd_1_july15
Firstcall simmonds marshall_ltd_1_july15IndiaNotes.com
 
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yFirstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yIndiaNotes.com
 
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950IndiaNotes.com
 
Will rapid urbanisation propel growth in Hitech Plast?
Will rapid urbanisation propel growth in Hitech Plast?Will rapid urbanisation propel growth in Hitech Plast?
Will rapid urbanisation propel growth in Hitech Plast?IndiaNotes.com
 
http://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdf
http://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdfhttp://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdf
http://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdfIndiaNotes.com
 
Excel Crop Care: Net profit ramps up by 214% in FY14, buy
Excel Crop Care: Net profit ramps up by 214% in FY14, buyExcel Crop Care: Net profit ramps up by 214% in FY14, buy
Excel Crop Care: Net profit ramps up by 214% in FY14, buyIndiaNotes.com
 
Firstcall atul 7may15[1]
Firstcall atul 7may15[1]Firstcall atul 7may15[1]
Firstcall atul 7may15[1]IndiaNotes.com
 
Fce tvs motors_28_jul15
Fce tvs motors_28_jul15Fce tvs motors_28_jul15
Fce tvs motors_28_jul15IndiaNotes.com
 
Buy KPR Mill: Large green field facility of 36 mln garments to be added
Buy KPR Mill: Large green field facility of 36 mln garments to be addedBuy KPR Mill: Large green field facility of 36 mln garments to be added
Buy KPR Mill: Large green field facility of 36 mln garments to be addedIndiaNotes.com
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'IndiaNotes.com
 
Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15IndiaNotes.com
 
AIA Engineering Q4FY15: Firstcall recommend for target of 1125
AIA Engineering Q4FY15: Firstcall recommend for target of 1125AIA Engineering Q4FY15: Firstcall recommend for target of 1125
AIA Engineering Q4FY15: Firstcall recommend for target of 1125IndiaNotes.com
 
Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'
Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'
Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'IndiaNotes.com
 
Go long on Simmonds Marshall for the mid- to long-term
Go long on Simmonds Marshall for the mid- to long-termGo long on Simmonds Marshall for the mid- to long-term
Go long on Simmonds Marshall for the mid- to long-termIndiaNotes.com
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buyIndiaNotes.com
 
Fce rashtriya chemicals_07jul15
Fce rashtriya chemicals_07jul15Fce rashtriya chemicals_07jul15
Fce rashtriya chemicals_07jul15IndiaNotes.com
 
Kitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; Buy
Kitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; BuyKitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; Buy
Kitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; BuyIndiaNotes.com
 

Was ist angesagt? (19)

GSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; Buy
GSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; BuyGSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; Buy
GSK Consumer: Operating Profit ramps up by 16.29% in Q4FY15; Buy
 
Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]
 
Firstcall simmonds marshall_ltd_1_july15
Firstcall simmonds marshall_ltd_1_july15Firstcall simmonds marshall_ltd_1_july15
Firstcall simmonds marshall_ltd_1_july15
 
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yFirstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
 
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
 
Will rapid urbanisation propel growth in Hitech Plast?
Will rapid urbanisation propel growth in Hitech Plast?Will rapid urbanisation propel growth in Hitech Plast?
Will rapid urbanisation propel growth in Hitech Plast?
 
http://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdf
http://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdfhttp://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdf
http://www.indianotes.com/uploads/article_pdf/2015/smc_SunPharma_04Jun15.pdf
 
Excel Crop Care: Net profit ramps up by 214% in FY14, buy
Excel Crop Care: Net profit ramps up by 214% in FY14, buyExcel Crop Care: Net profit ramps up by 214% in FY14, buy
Excel Crop Care: Net profit ramps up by 214% in FY14, buy
 
Firstcall atul 7may15[1]
Firstcall atul 7may15[1]Firstcall atul 7may15[1]
Firstcall atul 7may15[1]
 
Fce tvs motors_28_jul15
Fce tvs motors_28_jul15Fce tvs motors_28_jul15
Fce tvs motors_28_jul15
 
Buy KPR Mill: Large green field facility of 36 mln garments to be added
Buy KPR Mill: Large green field facility of 36 mln garments to be addedBuy KPR Mill: Large green field facility of 36 mln garments to be added
Buy KPR Mill: Large green field facility of 36 mln garments to be added
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
 
Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15Firstcall metroglobal limited_13jul15
Firstcall metroglobal limited_13jul15
 
AIA Engineering Q4FY15: Firstcall recommend for target of 1125
AIA Engineering Q4FY15: Firstcall recommend for target of 1125AIA Engineering Q4FY15: Firstcall recommend for target of 1125
AIA Engineering Q4FY15: Firstcall recommend for target of 1125
 
Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'
Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'
Castrol India clocks Q1CY15 net profit of INR1,467m; Firstcall recommends 'Buy'
 
Go long on Simmonds Marshall for the mid- to long-term
Go long on Simmonds Marshall for the mid- to long-termGo long on Simmonds Marshall for the mid- to long-term
Go long on Simmonds Marshall for the mid- to long-term
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 
Fce rashtriya chemicals_07jul15
Fce rashtriya chemicals_07jul15Fce rashtriya chemicals_07jul15
Fce rashtriya chemicals_07jul15
 
Kitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; Buy
Kitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; BuyKitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; Buy
Kitex: ICRA upgrades long and short-term ratings to AA minus and A one Plus; Buy
 

Ähnlich wie Grasim Industries reports improved performance in Q1FY16

Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592
 Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592 Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592
Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592IndiaNotes.com
 
Ambuja Cements Ltd. Q3 CY15 Result Update
Ambuja Cements Ltd. Q3 CY15 Result UpdateAmbuja Cements Ltd. Q3 CY15 Result Update
Ambuja Cements Ltd. Q3 CY15 Result Updatechoice broking
 
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...IndiaNotes.com
 
Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220IndiaNotes.com
 
M&m ru2 qfy2011-291010
M&m ru2 qfy2011-291010M&m ru2 qfy2011-291010
M&m ru2 qfy2011-291010Angel Broking
 
M&M- Q3FY16 Result Update
M&M- Q3FY16 Result UpdateM&M- Q3FY16 Result Update
M&M- Q3FY16 Result Updatechoice broking
 
Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
 Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
Heidelberg Cement reports superlative set of numbers for Q1FY15; HoldIndiaNotes.com
 
Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016
Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016
Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016Omneya El Hammamy
 
Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19Karan Agarwal
 
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...hdfcsecurities1
 
Apar Industries_Q2FY15_Nov'14_Eisec
Apar Industries_Q2FY15_Nov'14_EisecApar Industries_Q2FY15_Nov'14_Eisec
Apar Industries_Q2FY15_Nov'14_EisecPushkaraj Jamsandekar
 
Crompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buyCrompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buyIndiaNotes.com
 
Akzo Nobel India- Result Analysis Q2FY16
Akzo Nobel India- Result Analysis Q2FY16Akzo Nobel India- Result Analysis Q2FY16
Akzo Nobel India- Result Analysis Q2FY16choice broking
 
Acc ru3 qcy2010-211010
Acc ru3 qcy2010-211010Acc ru3 qcy2010-211010
Acc ru3 qcy2010-211010Angel Broking
 
Investing in Bangladesh Capiy
Investing in Bangladesh CapiyInvesting in Bangladesh Capiy
Investing in Bangladesh CapiyAsrarul Haque
 
Investing in Bangladesh Capital Market
Investing in Bangladesh Capital MarketInvesting in Bangladesh Capital Market
Investing in Bangladesh Capital MarketMohammad Asrarul Haque
 
Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Angel Broking
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldIndiaNotes.com
 
Rudra Shares Fundamental Call Report- Bodal chemicals ltd
 Rudra Shares Fundamental Call Report- Bodal chemicals  ltd Rudra Shares Fundamental Call Report- Bodal chemicals  ltd
Rudra Shares Fundamental Call Report- Bodal chemicals ltdAnkurShah108
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 

Ähnlich wie Grasim Industries reports improved performance in Q1FY16 (20)

Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592
 Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592 Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592
Ultratech Cement Q1FY15: Buy at CMP for target of Rs2592
 
Ambuja Cements Ltd. Q3 CY15 Result Update
Ambuja Cements Ltd. Q3 CY15 Result UpdateAmbuja Cements Ltd. Q3 CY15 Result Update
Ambuja Cements Ltd. Q3 CY15 Result Update
 
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
Coal India Q1FY15: Revenues stable on steady volumes and healthy realizations...
 
Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220
 
M&m ru2 qfy2011-291010
M&m ru2 qfy2011-291010M&m ru2 qfy2011-291010
M&m ru2 qfy2011-291010
 
M&M- Q3FY16 Result Update
M&M- Q3FY16 Result UpdateM&M- Q3FY16 Result Update
M&M- Q3FY16 Result Update
 
Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
 Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
 
Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016
Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016
Sidi Kerir Petrochemicals - SIDPEC - Re-initiation of Coverage - 6 April 2016
 
Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19Narayan hrudyalaya Q1FY19
Narayan hrudyalaya Q1FY19
 
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
 
Apar Industries_Q2FY15_Nov'14_Eisec
Apar Industries_Q2FY15_Nov'14_EisecApar Industries_Q2FY15_Nov'14_Eisec
Apar Industries_Q2FY15_Nov'14_Eisec
 
Crompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buyCrompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buy
 
Akzo Nobel India- Result Analysis Q2FY16
Akzo Nobel India- Result Analysis Q2FY16Akzo Nobel India- Result Analysis Q2FY16
Akzo Nobel India- Result Analysis Q2FY16
 
Acc ru3 qcy2010-211010
Acc ru3 qcy2010-211010Acc ru3 qcy2010-211010
Acc ru3 qcy2010-211010
 
Investing in Bangladesh Capiy
Investing in Bangladesh CapiyInvesting in Bangladesh Capiy
Investing in Bangladesh Capiy
 
Investing in Bangladesh Capital Market
Investing in Bangladesh Capital MarketInvesting in Bangladesh Capital Market
Investing in Bangladesh Capital Market
 
Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
 
Rudra Shares Fundamental Call Report- Bodal chemicals ltd
 Rudra Shares Fundamental Call Report- Bodal chemicals  ltd Rudra Shares Fundamental Call Report- Bodal chemicals  ltd
Rudra Shares Fundamental Call Report- Bodal chemicals ltd
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 

Mehr von IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15IndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15IndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNotes.com
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyIndiaNotes.com
 
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesIndiaNotes.com
 
Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15IndiaNotes.com
 
Fce sqs india_29_jul15
Fce sqs india_29_jul15Fce sqs india_29_jul15
Fce sqs india_29_jul15IndiaNotes.com
 
Nb maxwell 29_july15
Nb  maxwell 29_july15Nb  maxwell 29_july15
Nb maxwell 29_july15IndiaNotes.com
 

Mehr von IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
 
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
 
Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15
 
Fce sqs india_29_jul15
Fce sqs india_29_jul15Fce sqs india_29_jul15
Fce sqs india_29_jul15
 
Nb maxwell 29_july15
Nb  maxwell 29_july15Nb  maxwell 29_july15
Nb maxwell 29_july15
 

KĂŒrzlich hochgeladen

Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...batoole333
 
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai MultipleDubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiplekojalpk89
 
Call Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budget
Call Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budgetCall Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budget
Call Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budgetSareena Khatun
 
ćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻ
ćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻ
ćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻyyawb
 
NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...
NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...
NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...sarkh428
 
Business Principles, Tools, and Techniques in Participating in Various Types...
Business Principles, Tools, and Techniques  in Participating in Various Types...Business Principles, Tools, and Techniques  in Participating in Various Types...
Business Principles, Tools, and Techniques in Participating in Various Types...jeffreytingson
 
Webinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumWebinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumFinTech Belgium
 
falcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesfalcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesFalcon Invoice Discounting
 
Pension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfPension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfHenry Tapper
 
Toronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdfToronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdfJinJiang6
 
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize ThemSignificant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them360factors
 
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...Henry Tapper
 
Mahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot GirlsMahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot GirlsDeepika Singh
 
cost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxcost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxazadalisthp2020i
 
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...Health
 
Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...
Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...
Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...janibaber266
 
+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...
+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...
+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...Health
 
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamsamsungultra782445
 
Group 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case StudiesGroup 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case StudiesNghiaPham100
 
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnLaw of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnTintoTom3
 

KĂŒrzlich hochgeladen (20)

Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
 
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai MultipleDubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
 
Call Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budget
Call Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budgetCall Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budget
Call Girls Howrah ( 8250092165 ) Cheap rates call girls | Get low budget
 
ćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻ
ćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻ
ćŠłäŒŠæŁźć€§ć­ŠæŻ•äžšèŻ
 
NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...
NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...
NO1 Verified Online Love Vashikaran Specialist Kala Jadu Expert Specialist In...
 
Business Principles, Tools, and Techniques in Participating in Various Types...
Business Principles, Tools, and Techniques  in Participating in Various Types...Business Principles, Tools, and Techniques  in Participating in Various Types...
Business Principles, Tools, and Techniques in Participating in Various Types...
 
Webinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumWebinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech Belgium
 
falcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesfalcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunities
 
Pension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfPension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdf
 
Toronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdfToronto dominion bank investor presentation.pdf
Toronto dominion bank investor presentation.pdf
 
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize ThemSignificant AI Trends for the Financial Industry in 2024 and How to Utilize Them
Significant AI Trends for the Financial Industry in 2024 and How to Utilize Them
 
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
 
Mahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot GirlsMahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot Girls
Mahendragarh Escorts đŸ„° 8617370543 Call Girls Offer VIP Hot Girls
 
cost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxcost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptx
 
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
 
Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...
Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...
Famous No1 Amil Baba Love marriage Astrologer Specialist Expert In Pakistan a...
 
+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...
+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...
+971565801893>>SAFE ORIGINAL ABORTION PILLS FOR SALE IN DUBAI,RAK CITY,ABUDHA...
 
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
 
Group 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case StudiesGroup 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case Studies
 
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnLaw of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
 

Grasim Industries reports improved performance in Q1FY16

  • 1. GRASIM INDUSTRIES LIMITED Current Price: Price (`) 3768.20 52 W H/L( ) 4023.60/3222.60 Mkt. Cap.( Cr) 34612.35 Latest Equity(Subscribed) 91.85 Latest Reserve (cons.) 22988.71 Latest EPS (cons.) -Unit Curr. 190.30 Latest P/E Ratio -cons 19.80 LatestBookvalue(cons.)-UnitCurr. 2512.75 Latest P/BV - cons 1.50 Dividend Yield -% 0.48 Face Value 10.00 ` ` VALUE PARAMETERS Consolidated Results In Cr. `3768.20`3768.20 STOCK DATA BSE Code 500300 NSE Symbol GRASIM Reuters GRAS.BO Bloomberg GRASIM IN SHARE HOLDING PATTERN (%) Description as on % of Holding 30/06/2015 Foreign 40.35 Institutions 17.57 Govt Holding 0.00 Non Promoter Corp. Hold. 6.76 Promoters 25.51 Public & Others 9.81 Grasim Industries, a flagship company of the Aditya Birla Group,has reported improved performance for the quarter ended June 2015, amidst challenging market conditions. Its consolidated net profit declined by 1% to `484.67 crore despite 7% jump in revenue to 8599.07 crore. OPM improved by 130 bps to 16.5%, due to drop in raw material and power & fuel cost partially offset by rise in freight and employee cost, thus, operating profit inclined by 16% to 1417.06 crore. With gain in interest outgo by 35% to 171.30 crore and depreciation by 13% to 403.04 crore, the PBT dropped by 5% to 956.64 crore. Consolidated results for the June quarter Topline jumps 7%-Consolidated net sales revenue of the company jumped 7% to 8599.07 crore for the first quarter ended June 2015, aided by growth in turnover for all three businesses, notably the VSF segment. The revenue from cement (Grey, White and Allied Products) division (contributes 74% of total revenue) grew 7% to 6432.15 crore, Viscose Staple Fibre and Wood Pulp division (contributes 19% of total revenue) rose 7% to 1664.37 crore and Chemicals (Caustic Soda and Allied Chemicals) segment (contributes 6% of total revenue) climbed 17% to 485.18 crore. Revenue from other segments (constitutes mainly textiles and contributes 2% of total revenue) fell 8% to 136.65 crore. OPM improves to 16.5% - Operating margin (OPM) inclined 130 bps to 16.5%. The improvement in OPM seems largely on account of decrease in power & fuel costs by 240 bps to 17.6%, raw material cost by 100 bps to 23.3%, and other cost by 40 bps to 14.7% as percentage to sales and net of stock adjustments. However, freight & handling costs increased by 210 bps to 19.7% and employee benefits cost jumped 30 bps to 6.5% during the period. As a result, operating profit advanced by 16% at 1417.06 crore. ` ` ` ` ` ` ` ` ` ` ` 1 Particulars Qtr Ending Qtr Ending Var. June 15 14 (%) Total Income 8599.07 8045.04 7 OPM (%) 16.48 15.14 9 OP 1417.06 1218.22 16 Other income 113.92 269.61 -58 PBIDT 1530.98 1487.83 3 Net Finance Charges 171.30 126.49 35 PBDT 1359.68 1361.34 0 Depreciation 403.04 357.76 13 PBT 956.64 1003.58 -5 Tax expense 281.07 304.05 -8 PAT 675.57 699.53 -3 Minority Interest 234.77 250.30 -6 Share of Profit of Associates 43.87 37.90 16 Profit after Minority Interest and Share of profit of Associates EPS (`) 52.76 53.04 June 484.67 487.13 -1 August 11, 2015
  • 2. 2 At segment level, PBIT of cement business gained 14% to 921.52 crore and Chemicals business rose 4% to 69.60 crore, while VSFand Wood Pulp business PBIT zoomed to 68.77 crore from 19.81 crore in previous corresponding quarter.The margins of cement business escalated 90 bps to 14.3%, while the VSF and Wood Pulp businessmargins grew 290 bps to 4.1% while margin of chemicals business sank 180 bps to 14.3%. Bottomline falls 1% on higher interest, depreciation- The other income was down 58% to 113.92 crore, thus the PBIDT rose by 3% to 1530.98 crore. The Company interest cost jumped 35% to 171.30and depreciation rose13% to 403.04 crore.Thus, the PBT shrank by 5% to 956.64 crore. The effective tax rate was down 90 bps to 29.4% during the quarter, thus, Tax Expense declined 8% to Rs 281.07 crore. After deducting tax expenses, the PAT before MI and Share of profits from Associate declined by 3% to 675.57 crore. After accounting Minority interest of Rs 234.77 crore, down 6%, and Share of profits from associates of 43.87 crore, up 16%, respectively, Consolidated Net Profit was down 1% to 484.67 crore. ` ` ` ` ` ` ` ` ` ` ` ` Consolidated Results In Cr. Particulars Qtr Ending Qtr Ending % Var. June 15 June 14 total (%) Segment Revenue Viscose Staple Fibre and Wood Pulp 1664.37 1558.58 19 7 Cement - Grey, White and Allied Products 6432.15 6032.36 74 7 Chemicals-CausticSodaandAlliedChemicals 485.18 414.20 6 17 Others 136.65 148.57 2 -8 Total 8718.35 8153.71 100 7 Less: Inter-segment Revenue 119.28 108.67 13 Net Sales/Income from Operations 8599.07 8045.04 10 Segment Results (Profit before Finance Cost & Taxes) Viscose Staple Fibre and Wood Pulp 68.77 19.81 6 247 Cement - Grey, White and Allied Products 921.52 809.38 86 14 Chemicals - Caustic Soda and Allied Chemicals 69.60 66.83 6 4 Others 11.56 10.70 1 8 Total 1071.45 906.72 100 18 Less: Finance Costs 171.30 126.49 35 Net Unallocable Income/ (Expenditure) 56.49 223.35 -75 Total Profit before EO and tax 956.64 1003.58 -5 Add: EO 0.00 0.00 Profit before Tax 956.64 1003.58 -5 Capital Employed (Segment Assets-Segment Liabilities) Viscose Staple Fibre and Wood Pulp 6979.85 7167.01 15 -3 Cement - Grey, White and Allied Products 30472.83 28197.99 65 8 Chemicals - Caustic Soda and Allied Chemicals 1949.04 1869.58 4 4 Others 318.08 287.57 1 11 Unallocated 6803.86 6684.11 15 2 Total 46523.66 44206.26 100 5 of
  • 3. 3 Viscose Staple Fibre (VSF) Revenue increased by 15% driven by higher sales volume at 103K MT, up 19%. EBIDTA surged by 72% at 139 crore. with expanded volumes and a decline in pulp and other input cost. The production at the newly commissioned Vilayat plant has ramped up. It achieved a capacity utilisation of ~82%. The volume growth would have been higher, had there been no plant stoppage at Nagda for two months due to the water shortage. Operations at Nagda resumed from the last week of June 2015. Chemical Business In the Chemical business, revenue soared by 17% as Epoxy volume almost doubled with ramping up of plant utilisation. Caustic soda sales volume was maintained at 98K Tons. EBITDA increased by 3% at 94 crore. The merger scheme of Aditya Birla Chemicals India Ltd. (ABCIL) with the Company has been approved by the Shareholders and Creditors of both the Companies. Post-merger, the caustic soda capacity of the Company will increase from 452K TPA to 804K TPA. The scheme will be effective from 1st April, 2015 upon receipt of requisite regulatory approvals inter-alia from Competition Commission of India and High courts, expected by Q3 FY16. Therefore, the Company's results do not include EBITDA of 78 crore. and PAT of 20 crore. reported by ABCIL for the current quarter. Cement Subsidiary (UltraTech Cement) Amidst subdued demand in the Cement sector due to slowdown in construction activities, UltraTech Cement has reported better performance. Its revenue for the quarter stood at 6,432 crore, up by 7% as compared to 6,032 crore in the corresponding quarter last year. The combined cement and clinker sales volume was 13.0 million tonnes against 12.4 million tonnes last year. EBITDA was 1,282 crore ( 1,296 crore) and Net profit was 591 crore ( 627 crore). With the reduction in fuel pricesand higher pet coke consumption, energy costs declined by 7%. Its benefit was partially offset by the increase in railway freight. Input prices remained stable, except for the rise in royalty on limestone and levies under the Mines and Mineral (Development and Regulation) Amendment Act, 2015. Outlook In the VSF business, prices are likely to be influenced by the development in the industry inChina amidst increase in the input prices and resumption of operations at some of the shut capacities. The Company's new plant at Vilayat with a higher share of speciality product will improve its product mix and realisations. The recently launched brand 'Liva' has met with good response from value chain and consumers. The Company is closely working with the brands, designers and retailers to expand its domestic market. In the Chemical business, the scale of operations will rise significantly post the merger of ABCILwith the Company. In Cement, the demand is expected to be higher with the Government's focus on infrastructuredevelopment, housing sector, smart cities etc. and the softening of interest rates. The Companyis well positioned across the country to cater growth in demand.The Company enjoys a leadership position in all its businesses: Cement, Viscose Staple Fibre andChemicals, which has been further strengthened having made an investment of US$4 billion overlast five years. The Company is well poised to reap the benefits of these investments withramping up of capacity utilisation and expected upturn in the business cycle led byaccelerated growth in the economy. ` ` ` ` ` ` ` ` ` `
  • 4. 3 SMC Global Securities Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a further public offering of its equity shares and has filed the Draft Red Herring Prospectus with the Securities and Exchange Board of India (“SEBI”) and the Stock Exchanges. The Draft Red Herring Prospectus is available on the website of SEBI at www.sebi.gov.in and on the websites of the Book Running Lead Manager i.e., ICICI Securities Limited at www.icicisecurities.com and the Co- Book Running Lead Manager i.e., Elara Capital (India) Private Limited at www.elaracapital.com . Investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, please see the section titled “Risk Factors” of the aforementioned offer document. Disclaimer: This report is for the personal information of the authorized recipient and doesn't construe to be any investment, legal or taxation advice to you. It is only for private circulation and use .The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. No action is solicited on the basis of the contents of the report. The report should not be reproduced or redistributed to any other person(s)in any form without prior written permission of the SMC. The contents of this material are general and are neither comprehensive nor inclusive. Neither SMC nor any of its affiliates, associates, representatives, directors or employees shall be responsible for any loss or damage that may arise to any person due to any action taken on the basis of this report. It does not constitute personal recommendations or take into account the particular investment objectives, financial situations or needs of an individual client or a corporate/s or any entity/s.All investments involve risk and past performance doesn't guarantee future results. The value of, and income from investments may vary because of the changes in the macro and micro factors given at a certain period of time. The person should use his/her own judgment while taking investment decisions. Please note that we and our affiliates, officers, directors, and employees, including persons involved in the preparation or issuance if this material;(a) from time to time, may have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned here in or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform investment banking services for such company(ies) or act as advisor or lender/borrower to such company(ies) or (c) may have any other potential conflict of interest with respect to any recommendation and related information and opinions.All disputes shall be subject to the exclusive jurisdiction of Delhi High court. Corporate Office: 11/6B, Shanti Chamber, Pusa Road, New Delhi - 110005 Tel: +91-11-30111000 www.smcindiaonline.com Mumbai Office: Dheeraj Sagar, 1st Floor, Opp. Goregaon sports club, link road Malad (West), Mumbai - 400064 Tel: 91-22-67341600, Fax: 91-22-28805606 Kolkata Office: 18, Rabindra Sarani, "Poddar Court", Gate No. 4, 4th Floor, Kolkata - 700001 Tel: 91-33-39847000, Fax: 91-33-39847004 E-mail: researchfeedback@smcindiaonline.com Âź SMC Research also available on Reuters SMC Global Securities Ltd. (hereinafter referred to as “SMC”) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and its associate is member of MCX stock Exchange Limited. It is also registered as a Depository Participant with CDSL and NSDL. Its associates merchant banker and Portfolio Manager are registered with SEBI and NBFC registered with RBI. It also has registration withAMFI as a Mutual Fund Distributor. SMC has applied with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. SMC or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. SMC or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered byAnalyst. SMC or its associates and relatives does not have any material conflict of interest. SMC or its associates/analyst has not received any compensation from the company covered byAnalyst during the past twelve months. The subject company has not been a client of SMC during the past twelve months. SMC or its associates has not received any compensation or other benefits from the company covered by analyst or third party in connection with the research report. TheAnalyst has not served as an officer, director or employee of company covered byAnalyst and SMC has not been engaged in market making activity of the company covered byAnalyst. The views expressed are based solely on information available publicly available/internal data/ other reliable sources believed to be true. SMC does not represent/ provide any warranty express or implied to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. SMC Research Desk Source: Company Website Reuters Capitaline